How Long Do Hep A and B Shots Last?

Hepatitis A and B vaccines provide long-lasting protection after the recommended series is completed. Most healthy people do not need routine booster doses, although certain people with ongoing exposure risks or weakened immunity may need individualized medical advice.

How long do Hep A and B shots last?

Hepatitis A vaccine protection generally lasts at least 20 years in healthy adults after the full series, and likely persists much longer. Hepatitis B vaccine protection lasts at least 30 years in healthy people who complete the recommended series, even if antibody levels measured in blood decline over time. For most people, routine booster shots are not needed once the full series has been documented.

These vaccines prevent two different viral liver infections. Hepatitis A usually spreads through contaminated food, water, or close personal contact, while hepatitis B spreads through blood and certain body fluids. Both vaccines are highly effective when given correctly, but their schedules, follow-up needs, and reasons for testing differ.

It is common to be unsure whether protection is still present years after childhood, travel, employment, or pregnancy-related vaccination. In many cases, a vaccination record is more useful than repeating blood tests. A doctor can review the person’s age, health conditions, vaccination history, travel plans, and possible exposure risks to determine whether any action is needed.

Hepatitis A vaccine: duration and schedule

Hepatitis A vaccination is usually given as a two-dose series, with the doses separated by at least six months. After both doses, protection is long-lasting. Studies have shown persistent protection for at least two decades in adults, and experts expect immune memory to continue for much longer in most healthy people.

Children may receive hepatitis A vaccine routinely in some national immunization programs, often beginning at 12 months of age. Adults may be advised to receive it before travel to areas where hepatitis A is common, or because of occupational, medical, or lifestyle-related exposure risks. One dose offers meaningful short-term protection, but the second dose is important for durable protection.

Healthy people who have completed the two-dose series do not usually need a booster. If the second dose was delayed, the series can generally be completed without starting over. A clinician or immunization service can help interpret incomplete records and choose the most appropriate next step.

People with chronic liver disease may be particularly encouraged to receive hepatitis A vaccination because a hepatitis A infection can be more serious when the liver is already affected. Hepatitis A itself is usually an acute infection and does not become chronic; readers can learn more about hepatitis A.

Hepatitis B vaccine: duration and schedule

Hepatitis B vaccination protects against a virus that can cause acute or chronic liver infection. In healthy people who complete an approved vaccine schedule, protection has been shown to last at least 30 years. Although the measurable amount of antibody in the blood may decrease naturally over time, the immune system usually retains memory and can respond quickly if exposed to the virus.

The standard hepatitis B schedule often involves two, three, or four doses depending on the vaccine product, the person’s age, and the timing of doses. Infants commonly receive the first dose shortly after birth. Adults who were not vaccinated earlier can also be vaccinated, and accelerated schedules may sometimes be used when protection is needed more quickly, such as before travel.

For immunocompetent people with documented completion of the series, routine antibody testing and routine boosters are not recommended in most settings. This can be reassuring for people who were vaccinated many years ago: a low or undetectable antibody result does not automatically mean that protection has disappeared or that another full series is necessary.

Hepatitis B can become chronic and may cause serious liver complications over time, which is why prevention and timely assessment after possible exposure are important. More information is available in this overview of hepatitis B.

Who may need a booster or blood test?

Most healthy adults and children do not need hepatitis A or hepatitis B booster doses after completing their recommended series. However, certain groups may need a more individualized plan. This does not mean the vaccine has failed; it reflects the possibility that the immune response may be less predictable in people with particular medical conditions or ongoing exposure risks.

For hepatitis B, post-vaccination blood testing may be recommended for some healthcare personnel who may be exposed to blood, infants born to a parent with hepatitis B infection, people receiving hemodialysis, and people with certain immune-suppressing conditions or treatments. Testing is also often considered for sexual partners of people with hepatitis B. The test typically measures hepatitis B surface antibody and is performed at a clinically appropriate time after vaccination.

People receiving dialysis may need periodic antibody testing and booster doses according to local guidelines. Those who have had an organ transplant, are receiving chemotherapy, take significant immune-suppressing medication, or live with advanced immune deficiency should ask their specialist whether testing or revaccination is appropriate. Recommendations depend on the individual situation rather than age alone.

A combined hepatitis A and B vaccine is also available in some countries. It is usually given as a multi-dose series and can be convenient when protection against both viruses is needed. Completing every scheduled dose remains the best way to achieve reliable, long-lasting protection.

What if vaccine records are missing or doses were missed?

Missing records are common, especially for vaccines received in childhood or in another country. A clinician may first check national or local immunization registries, previous medical records, school records, travel clinic documentation, or occupational health files. If proof of a completed series cannot be found, vaccination may be recommended based on the person’s risk profile and local guidance.

In general, an interrupted hepatitis A or hepatitis B series does not need to be restarted. The missed dose can usually be given as soon as practical, with the remaining doses scheduled at appropriate intervals. This approach avoids unnecessary repeat doses while still allowing the person to complete protection.

Blood tests are not always the best way to reconstruct vaccination history. For hepatitis B especially, an antibody level may fall years after successful vaccination while immune memory remains. A clinician may therefore recommend vaccination rather than relying on a single blood test, particularly when rapid and dependable protection is important.

People planning international travel should address uncertain vaccine status well before departure whenever possible. A travel medicine clinician can review destination-specific risks, planned activities, departure timing, and whether additional preventive measures may be helpful.

When to seek medical care

Most questions about old hepatitis A or B vaccinations are not urgent and can be discussed during a routine medical appointment, travel consultation, or occupational health visit. Medical review is especially helpful before travel, after a possible exposure to blood or body fluids, when starting immune-suppressing treatment, or when there is uncertainty about whether a vaccine series was completed.

Prompt medical advice is important after a possible hepatitis B exposure, such as a needlestick injury, unprotected sexual contact with a person known or suspected to have hepatitis B, or contact with blood. Post-exposure prevention may be time-sensitive. A clinician will assess the exposure, vaccination records, and whether blood tests, vaccine doses, or hepatitis B immune globulin may be needed.

Urgent assessment is also appropriate for symptoms that could suggest significant liver illness, including yellowing of the skin or eyes, very dark urine, pale stools, persistent vomiting, severe abdominal pain, confusion, unusual sleepiness, or easy bleeding. These symptoms have many possible causes and do not necessarily mean hepatitis, but they should not be ignored.

A doctor may take a detailed exposure and vaccination history, examine the person, and arrange blood tests when indicated. Tests can assess liver inflammation, look for current hepatitis infection, and evaluate hepatitis B immunity in selected circumstances. Acıbadem Health Point’s multidisciplinary specialists and JCI-accredited hospitals can assess hepatitis concerns and vaccination needs for international patients.

Staying protected: practical prevention steps

Vaccination is the most dependable way to prevent hepatitis A and hepatitis B, but everyday prevention remains valuable. Hepatitis A risk can be reduced through careful handwashing, safe food and water choices during travel, and avoiding food prepared in unhygienic conditions. These measures are particularly important in places where sanitation infrastructure may vary.

Hepatitis B prevention includes avoiding shared needles or injection equipment, using sterile equipment for tattoos or piercings, and practicing safer sex. Personal items that may carry traces of blood, such as razors, toothbrushes, nail clippers, or glucose-monitoring supplies, should not be shared. Pregnant people should be screened for hepatitis B so newborn prevention can be arranged when needed.

People living with chronic liver disease should discuss hepatitis A and B vaccination with their clinician if they are not already immune. Avoiding excessive alcohol, using medicines only as directed, and informing healthcare professionals about supplements or herbal products can also support liver health. Vaccination does not replace medical follow-up for existing liver disease.

Anyone who develops new questions after a possible exposure should seek qualified medical advice rather than waiting for symptoms. Hepatitis infections may cause few or no symptoms early on, and timely testing or preventive treatment can make an important difference.

Frequently asked questions